查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679220

2030 年醫用聚合物市場預測：按產品類型、製造流程、應用和地區進行的全球分析

Medical Polymers Market Forecasts to 2030 - Global Analysis By Product Type (Biodegradable Polymers and Non-Biodegradable Polymers), Manufacturing Process, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球醫用聚合物市場預計在 2024 年達到 413 億美元，到 2030 年將達到 682 億美元，預測期內的複合年成長率為 8.7%。

醫用聚合物是用於藥物輸送系統、包裝、植入和醫療設備的專用材料。這些聚合物具有耐用性、靈活性和生物相容性。其中包括矽膠、聚乙烯、聚丙烯和生物分解性。它對於手術器械、義肢、導管和藥品包裝的製造至關重要。它們的輕量化設計、耐化學性和無菌性對現代醫學至關重要，因為它們可確保各種醫療應用中的患者安全、療效和更好的結果。

根據PMC的研究，美國消耗了全球製造的約40%的醫療設備，其次是歐洲和日本。

醫療設備和植入需求不斷成長

慢性病的增加和人口老化正在推動醫療設備和植入產業的顯著成長。對先進醫療工具、儀器和植入的需求激增直接推動了醫用聚合物市場的發展。先進的聚合物技術使得創造出尖端的醫療設備成為可能，這些設備可確保生物相容性、彈性以及在醫療環境中易於消毒的程序，使其成為現代醫療保健服務中必不可少的。

原料成本上漲

醫用聚合物製造成本的上升對市場成長構成了重大挑戰。製造過程需要專門的設備、熟練的勞動力和大量的能源投入，而原料往往稀缺且昂貴。它們的生產成本比傳統聚合物高達五倍，這使得它們在許多應用領域中經濟上難以承受，也限制了它們在成本敏感領域的廣泛使用。

擴大藥物傳輸應用

生物製藥和個人化醫療的發展為基於聚合物的藥物輸送系統創造了重大機會。先進的聚合物配方能夠控制和延長藥物的釋放，從而提高治療效果和患者依從性。 3D 列印和奈米技術等新技術的融合，使得藥物配方更加精確、可客製化，刺激了研發投資。

產品責任及召回風險

對醫療設備原始設計的任何更改或補充都會使召回風險增加約 30%。基於聚合物的醫療設備非常複雜，且受到嚴格的監管要求，因此存在巨大的責任風險。最近的研究表明某些聚合物對健康有不利影響，引發了安全擔憂，這可能會影響市場成長並要求製造商保持嚴格的品管措施。

COVID-19 的影響：

COVID-19 疫情對醫用聚合物市場產生了積極影響，主要是由於對疫苗接種用一次性注射器的需求增加。製藥業的繁榮透過增加對藥品包裝的要求，為市場的成長做出了巨大的貢獻。全球感染疾病威脅凸顯了醫用聚合物在醫療保健應用中的重要性，加速了市場擴張。

預測期內，非生物分解聚合物市場預計將成為最大的市場

由於其優異的耐用性、耐化學性和成熟的製造程序，預計非生物分解聚合物將在預測期內佔據最大的市場佔有率。這些材料廣泛應用於長期醫療設備、手術器械和醫療包裝應用。這種可靠性，加上在關鍵醫療應用中經過驗證的性能，使其成為醫療保健提供者和醫療設備製造商的首選，確保了其持續的市場主導。

預計組織工程和再生醫學領域將在預測期內見證最高的複合年成長率。

由於技術進步和生物技術投資的增加，組織工程和再生醫學領域預計將在預測期內見證最高成長率。用於組織再生的創新聚合物支架和基質的開發為再生醫學開闢了新的可能性。研究活動的活性化和對先進治療解決方案的需求不斷成長進一步支持了這一領域的擴張。

佔比最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於廣泛的醫療保健基礎設施和先進醫療技術的高度採用。平價醫療法案和醫療補助等政府關鍵舉措增強了該地區的優勢，擴大了醫療保健的機會並增加了對醫療設備和藥品包裝的需求。

複合年成長率最高的地區：

在預測期內，由於醫療保健行業的快速擴張和醫療旅遊業的興起，預計亞太地區將呈現最高的複合年成長率。泰國、新加坡和印度等國家正成為主要的醫療旅遊目的地，刺激了對先進醫療設備和植入的需求。政府措施和不斷增加的醫療支出進一步支持了該地區的成長。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球醫用聚合物市場（依產品類型）

  • 生物分解性聚合物
    • 聚乳酸（PLA）
    • 聚羥基烷酯(PHA)
    • 其他生物分解性聚合物
  • 非生物分解的聚合物
    • 通用聚合物
      • 聚丙烯（PP）
      • 聚乙烯 (PE)
      • 聚氯乙烯（PVC）
      • 聚苯乙烯（PS）
    • 工程樹脂
      • 聚氨酯 (PU)
      • 聚甲基丙烯酸甲酯 (PMMA)
      • 聚碳酸酯（PC）
      • 其他工程樹脂
    • 醫用合成橡膠
      • 熱可塑性橡膠(TPE)
      • 矽橡膠
      • 苯乙烯嵌段共聚物
    • 高性能聚合物
      • PEEK（聚醚醚酮）
      • PEI（聚醚醯亞胺）
      • PPSU（聚苯碸）
      • 液晶聚合物（LCP）

6. 全球醫用聚合物市場依製造流程分類

  • 初級處理
    • 射出成型
    • 擠壓
    • 壓縮成型
    • 吹塑成型
    • 鑄件
  • 進階處理
    • 3D 列印
    • 熱成型
    • 表面處理
    • 連接技術

7. 全球醫用聚合物市場（按應用）

  • 醫療一次性用品
  • 醫療設備
  • 藥物輸送系統
  • 義肢和矯正器具
  • 組織工程與再生醫學
  • 診斷設備和工具
  • 醫療包裝

8. 全球醫用聚合物市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章 主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司概況

  • Medtronic PLC
  • Johnson & Johnson
  • DowDuPont
  • BASF SE
  • Evonik Industries AG
  • Covestro AG
  • Asahi Kasei Corporation
  • DSM
  • Mitsubishi Chemical Corporation
  • Lubrizol Corporation
  • SABIC
  • Solvay SA
  • Arkema SA
  • Celanese Corporation
  • Eastman Chemical Company
  • Kraton Corporation
  • Tekni-Plex, Inc.
  • Victrex plc
Product Code: SMRC28803

According to Stratistics MRC, the Global Medical Polymers Market is accounted for $41.3 billion in 2024 and is expected to reach $68.2 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Medical polymers are specialty materials utilized in drug delivery systems, packaging, implants, and medical equipment. These polymers provide durability, flexibility, and biocompatibility. They include silicone, polyethylene, polypropylene, and biodegradable varieties. They are essential to the production of surgical equipment, prosthesis, catheters, and pharmaceutical packaging. They are crucial to modern medicine because of their lightweight design, chemical resistance, and sterilizability, which guarantee patient safety, effectiveness, and better results in a range of medical applications.

According to PMC studies, the US consumes around 40% of medical devices manufactured globally, followed by Europe and Japan.

Market Dynamics:

Driver:

Rising demand for medical devices and implants

The increasing prevalence of chronic diseases and aging population is driving substantial growth in the medical devices and implants sector. The surge in demand for sophisticated medical tools, apparatus, and implants has directly boosted the medical polymers market. Advanced polymer technology has enabled the creation of cutting-edge medical devices that ensure biocompatibility, resilience, and straightforward sterilization procedures in medical environments, making them essential for modern healthcare delivery.

Restraint:

High cost of raw materials

The elevated production costs of medical polymers pose significant challenges to market growth. The manufacturing processes require specialized equipment, skilled labor, and considerable energy input, while raw materials are often rare and expensive. The production costs can be up to five times higher than conventional polymers, making them economically challenging for many applications and limiting widespread adoption across cost-sensitive sectors.

Opportunity:

Expanding applications in drug delivery

The growth in biopharmaceuticals and personalized medicine has created significant opportunities for polymer-based drug delivery systems. Advanced polymeric formulations enable controlled and prolonged release of medications, enhancing treatment efficacy and patient adherence. The integration of novel technologies like 3D printing and nanotechnology is improving the precision and customization of drug formulations, driving investment in research and development.

Threat:

Product liability and recall risks

Medical devices face approximately 30% increased risk of recalls following modifications and supplements to their original design. The complexity of polymer-based medical devices and stringent regulatory requirements create significant liability risks. Recent studies linking certain polymers to adverse health effects have raised safety concerns, potentially impacting market growth and requiring manufacturers to maintain rigorous quality control measures.

Covid-19 Impact:

The Covid-19 pandemic had a positive impact on the medical polymers market, primarily driven by increased demand for single-use syringes for vaccinations. The thriving pharmaceutical industry contributed significantly to market growth through elevated requirements for medication packaging. The global threat of infectious diseases highlighted the importance of medical polymers in healthcare applications, accelerating market expansion.

The non-biodegradable polymers segment is expected to be the largest during the forecast period

The non-biodegradable polymers segment is expected to account for the largest market share during the forecast period due to their superior durability, chemical resistance, and established manufacturing processes. These materials are extensively used in long-term medical devices, surgical instruments, and medical packaging applications. Their reliability, coupled with proven performance in critical medical applications, has made them the preferred choice for healthcare providers and medical device manufacturers, ensuring their continued market leadership.

The tissue engineering & regenerative medicine segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the tissue engineering & regenerative medicine segment is predicted to witness the highest growth rate due to technological advancements and increasing investment in biotechnology. The development of innovative polymer-based scaffolds and matrices for tissue regeneration has opened new possibilities in regenerative medicine. This segment's expansion is further supported by growing research activities and the rising demand for advanced healing solutions.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by extensive healthcare infrastructure and high adoption of advanced medical technologies. The region's dominance is reinforced by significant government initiatives like the Affordable Care Act and Medicaid, which have expanded healthcare access and increased demand for medical devices and pharmaceutical packaging.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid healthcare sector expansion and increasing medical tourism. Countries like Thailand, Singapore, and India are emerging as major medical tourism destinations, fueling demand for sophisticated medical devices and implants. The region's growth is further supported by government initiatives and increasing healthcare expenditure.

Key players in the market

Some of the key players in Medical Polymers Market include Medtronic PLC, Johnson & Johnson, DowDuPont, BASF SE, Evonik Industries AG, Covestro AG, Asahi Kasei Corporation, DSM, Mitsubishi Chemical Corporation, Lubrizol Corporation, SABIC, Solvay S.A., Arkema S.A., Celanese Corporation, Eastman Chemical Company, Kraton Corporation, Tekni-Plex, Inc. and Victrex plc.

Key Developments:

In October 2024, The Japanese technology company Asahi Kasei signed a memorandum of understanding (MOU) with Aquafil S.p.A., an Italian manufacturer of polyamide 6 (PA6). The two companies agreed to develop a novel material for 3D printing (3DP) applications utilizing Aquafil's ECONYL(R) Polymer chemically recycled PA6 and Asahi Kasei's cellulose nanofiber (CNF), with the support of ITOCHU Corporation, which has made a capital investment in Aquafil. Pellets or filaments of this compound achieve superior formability and strength, which make them suitable for use in automotive and aeronautical applications.

In September 2024, Evonik has officially opened a new facility for drying aqueous dispersions of EUDRAGIT(R) polymers at its site in Darmstadt. The new double-digit million-euro excipient manufacturing facility enables Evonik to meet the increasing demand from pharmaceutical customers for oral drug delivery solutions. By expanding production capacities, Evonik is improving supply security and shortening delivery times for EUDRAGIT(R) polymers. The new plant also operates using green electricity and steam generated from local waste incineration, saving more than 1,000 tons of CO2 equivalents per year.

In October 2023, BASF changed its European direct business for Ultraform(R) (POM) and transfer the sales process to its long-standing trusted trading partners, ALBIS and Ultrapolymers Group. Ultraform(R) is and will remain an important part of BASF's engineering plastics portfolio. By maintaining research and development for Ultraform(R) within BASF, customers will continue to benefit from BASF's innovations and broad expertise, especially in solving technical challenges.

Product Types Covered:

  • Biodegradable Polymers
  • Non-biodegradable Polymers

Manufacturing Process Covered:

  • Primary Processing
  • Advanced Processing

Applications Covered:

  • Medical Disposables
  • Medical Devices & Equipment
  • Drug Delivery Systems
  • Prosthetics & Orthotics
  • Tissue Engineering & Regenerative Medicine
  • Diagnostic Instruments & Tools
  • Medical Packaging

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Polymers Market, By Product Type

  • 5.1 Introduction
  • 5.2 Biodegradable Polymers
    • 5.2.1 Polylactic Acid (PLA)
    • 5.2.2 Polyhydroxyalkanoates (PHA)
    • 5.2.3 Other Biodegradable Polymers
  • 5.3 Non-biodegradable Polymers
    • 5.3.1 Commodity Polymers
      • 5.3.1.1 Polypropylene (PP)
      • 5.3.1.2 Polyethylene (PE)
      • 5.3.1.3 Polyvinyl Chloride (PVC)
      • 5.3.1.4 Polystyrene (PS)
    • 5.3.2 Engineering Resins
      • 5.3.2.1 Polyurethane (PU)
      • 5.3.2.2 Polymethyl Methacrylate (PMMA)
      • 5.3.2.3 Polycarbonate (PC)
      • 5.3.2.4 Other Engineering Resins
    • 5.3.3 Medical Elastomers
      • 5.3.3.1 Thermoplastic Elastomers (TPE)
      • 5.3.3.2 Silicone Elastomers
      • 5.3.3.3 Styrenic Block Copolymers
    • 5.3.4 High-Performance Polymers
      • 5.3.4.1 PEEK (Polyether Ether Ketone)
      • 5.3.4.2 PEI (Polyetherimide)
      • 5.3.4.3 PPSU (Polyphenylsulfone)
      • 5.3.4.4 Liquid Crystal Polymers (LCPs)

6 Global Medical Polymers Market, By Manufacturing Process

  • 6.1 Introduction
  • 6.2 Primary Processing
    • 6.2.1 Injection Molding
    • 6.2.2 Extrusion
    • 6.2.3 Compression Molding
    • 6.2.4 Blow Molding
    • 6.2.5 Cast Molding
  • 6.3 Advanced Processing
    • 6.3.1 3D Printing
    • 6.3.2 Thermoforming
    • 6.3.3 Surface Treatment
    • 6.3.4 Joining Techniques

7 Global Medical Polymers Market, By Application

  • 7.1 Introduction
  • 7.2 Medical Disposables
  • 7.3 Medical Devices & Equipment
  • 7.4 Drug Delivery Systems
  • 7.5 Prosthetics & Orthotics
  • 7.6 Tissue Engineering & Regenerative Medicine
  • 7.7 Diagnostic Instruments & Tools
  • 7.8 Medical Packaging

8 Global Medical Polymers Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Medtronic PLC
  • 10.2 Johnson & Johnson
  • 10.3 DowDuPont
  • 10.4 BASF SE
  • 10.5 Evonik Industries AG
  • 10.6 Covestro AG
  • 10.7 Asahi Kasei Corporation
  • 10.8 DSM
  • 10.9 Mitsubishi Chemical Corporation
  • 10.10 Lubrizol Corporation
  • 10.11 SABIC
  • 10.12 Solvay S.A.
  • 10.13 Arkema S.A.
  • 10.14 Celanese Corporation
  • 10.15 Eastman Chemical Company
  • 10.16 Kraton Corporation
  • 10.17 Tekni-Plex, Inc.
  • 10.18 Victrex plc

List of Tables

  • Table 1 Global Medical Polymers Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Medical Polymers Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Medical Polymers Market Outlook, By Biodegradable Polymers (2022-2030) ($MN)
  • Table 4 Global Medical Polymers Market Outlook, By Polylactic Acid (PLA) (2022-2030) ($MN)
  • Table 5 Global Medical Polymers Market Outlook, By Polyhydroxyalkanoates (PHA) (2022-2030) ($MN)
  • Table 6 Global Medical Polymers Market Outlook, By Other Biodegradable Polymers (2022-2030) ($MN)
  • Table 7 Global Medical Polymers Market Outlook, By Non-biodegradable Polymers (2022-2030) ($MN)
  • Table 8 Global Medical Polymers Market Outlook, By Commodity Polymers (2022-2030) ($MN)
  • Table 9 Global Medical Polymers Market Outlook, By Engineering Resins (2022-2030) ($MN)
  • Table 10 Global Medical Polymers Market Outlook, By Medical Elastomers (2022-2030) ($MN)
  • Table 11 Global Medical Polymers Market Outlook, By High-Performance Polymers (2022-2030) ($MN)
  • Table 12 Global Medical Polymers Market Outlook, By Manufacturing Process (2022-2030) ($MN)
  • Table 13 Global Medical Polymers Market Outlook, By Primary Processing (2022-2030) ($MN)
  • Table 14 Global Medical Polymers Market Outlook, By Injection Molding (2022-2030) ($MN)
  • Table 15 Global Medical Polymers Market Outlook, By Extrusion (2022-2030) ($MN)
  • Table 16 Global Medical Polymers Market Outlook, By Compression Molding (2022-2030) ($MN)
  • Table 17 Global Medical Polymers Market Outlook, By Blow Molding (2022-2030) ($MN)
  • Table 18 Global Medical Polymers Market Outlook, By Cast Molding (2022-2030) ($MN)
  • Table 19 Global Medical Polymers Market Outlook, By Advanced Processing (2022-2030) ($MN)
  • Table 20 Global Medical Polymers Market Outlook, By 3D Printing (2022-2030) ($MN)
  • Table 21 Global Medical Polymers Market Outlook, By Thermoforming (2022-2030) ($MN)
  • Table 22 Global Medical Polymers Market Outlook, By Surface Treatment (2022-2030) ($MN)
  • Table 23 Global Medical Polymers Market Outlook, By Joining Techniques (2022-2030) ($MN)
  • Table 24 Global Medical Polymers Market Outlook, By Application (2022-2030) ($MN)
  • Table 25 Global Medical Polymers Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 26 Global Medical Polymers Market Outlook, By Medical Devices & Equipment (2022-2030) ($MN)
  • Table 27 Global Medical Polymers Market Outlook, By Drug Delivery Systems (2022-2030) ($MN)
  • Table 28 Global Medical Polymers Market Outlook, By Prosthetics & Orthotics (2022-2030) ($MN)
  • Table 29 Global Medical Polymers Market Outlook, By Tissue Engineering & Regenerative Medicine (2022-2030) ($MN)
  • Table 30 Global Medical Polymers Market Outlook, By Diagnostic Instruments & Tools (2022-2030) ($MN)
  • Table 31 Global Medical Polymers Market Outlook, By Medical Packaging (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.